Increases efficiency, reproducibility, and accuracy i in the electro-anatomical maps electrophysiologists use in catheter ablation procedures IRVINE, Calif., May 8, 2024 /PRNewswire/ -- Biosense ...

Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO® 3 MEM (Multi-Electrode Mapping)Version in the United States.

The heart beat is controlled by a system of electrical signals spreading from the top of the heart to the bottom. The electrical signal is initiated in an area of the upper right chamber, called the ...

DIAMOND BAR, Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today the launch of the CONFIDENSE™ Module, an innovative technology that ...

DIAMOND BAR, California, March 22, 2017 /PRNewswire/. Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, ...

With the CARTO™ 3 System software used in the study, clinicians were able to obtain a Pulsed Field (PF) Index value for each ablation, which is a calculation using the real-time contact force feedback ...

State-of-the-Art Software and new sensor-enabled catheter provides Electrophysiologists with an unparalleled level of speed and visualization in their 3D Mapping and Ablation procedures. FAM is a ...

The CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter allow for a patient-tailored ablation approach, resulting in high long-term effectiveness in persistent atrial fibrillation patients* IRVINE, ...